Yahoo! Fresenius' Pilot-Study News Good, Not Bad, for Affy
Affymax Inc.'s morning Wall Street sell-off reversed itself by the afternoon on Thursday, as shareholders began to understand what the decision by dialysis firm Fresenius Medical Care North America in contract negotiations with Affymax really meant.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5423
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST